This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Matthias Nauck - Innovator in Triglyceride Determination
Introduction
Matthias Nauck is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the determination of triglycerides in low-density lipoproteins. His work is essential for the diagnosis of vascular disorders, including coronary heart disease.
Latest Patents
Nauck holds a patent for a procedure that determines triglyceride levels contained in low-density lipoprotein. This innovative method involves reacting triglyceride-containing lipoprotein with a non-ionic surface-active agent synthesized from a block copolymer of propylene oxide and ethylene oxide. The procedure is particularly suitable for in-vitro diagnosis, enhancing the detection of vascular disorders.
Career Highlights
Matthias Nauck is associated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His work at Roche has allowed him to focus on developing advanced diagnostic procedures that improve patient outcomes.
Collaborations
Nauck has collaborated with Heinrich Wieland, contributing to the advancement of diagnostic technologies in the medical field.
Conclusion
Matthias Nauck's innovative work in triglyceride determination has made a significant impact on the diagnosis of vascular disorders. His contributions continue to enhance the field of medical diagnostics, benefiting both healthcare professionals and patients alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile